Table 2.
Sex hormone test data of the population included in the study.
| Sex Hormones | Total (n=135) | OSA patients | Non-OSA Subjects (n=11) | P | ||
|---|---|---|---|---|---|---|
| Total (n=124) | Mild to moderate (n=61) | Severe (n=63) | ||||
| PRL (ng/mL) |
18.88 (14.04~24.97) |
18.88 (14.09~24.38) |
18.81 (15.07~28.31) |
19.29 (13.99~22.79) |
19.55 (11.43~26.59) |
0.728 |
| FSH (mIU/mL) |
5.10 (3.80~6.84) |
5.00 (3.79~6.68) |
4.76 (2.98~5.73) |
5.26 (4.04~6.86) |
7.30 (3.73~12.46) |
0.062 |
| LH (mIU/mL) |
5.28 (3.85~6.76) |
5.06 (3.83~6.69) |
4.38 (3.82~6.90) |
5.20 (3.83~6.28) |
6.64 (5.36~7.47) |
0.294 |
| PROG (ng/mL) |
0.20 (0.13~0.30) |
0.20 (0.13~0.30) |
0.21 (0.11~0.30) |
0.20 (0.13~0.30) |
0.22 (0.14~0.54) |
0.821 |
| E2 (pg/mL) |
18.76 (12.82~22.95) |
18.89 (12.89~22.79) |
18.14 (15.46~20.37) |
19.67 (11.86~23.82) |
17.56 (10.26~44.79) |
0.686 |
| TEST (ng/mL) |
3.42 ± 1.14 | 3.36 ± 1.15 | 3.70 ± 1.17 | 3.24 ± 1.12 | 4.20 ± 0.81 | 0.056 |
FSH, Follicle stimulating hormone; LH, luteinizing hormone; and TEST, testosterone; E2, estradiol; PROG, progesterone; and PRL, prolactin.